Burn Injury Rewires Immune and Neuronal Extracellular Vesicle Communication [0.03%]
烧伤重塑免疫和神经细胞外囊泡通讯
Kristin N Grimsrud,Tajia Green,Yirui Tang et al.
Kristin N Grimsrud et al.
Objective: We examined extracellular vesicle (EV) protein alterations after burn injury to elucidate molecular pathways linking immune-neural communication and the pathophysiology of burns. ...
An Interrupted Time Series Analysis of 2023 Hernia CPT Revisions and Differential Effects on Private Practice Versus Academic Surgeons [0.03%]
2023年疝气CPT修订的中断时间序列分析及其对私人执业外科医生和学术型外科医生的不同影响
Krishay Sridalla,Nancy Ly,Megan Melland-Smith et al.
Krishay Sridalla et al.
Objectives: To evaluate the impact of the 2023 Current Procedural Terminology (CPT) coding changes on work relative value units (wRVUs), focusing on practice setting and hernia size. ...
Right (H145678) and Left (H123458) 6-Segmentectomies for Malignant Liver Tumors: A Retrospective Analysis of 237 Cases Using Contemporary Surgery Quality Indicators [0.03%]
右半肝(H145678)和左半肝(H123458)六段切除治疗肝脏恶性肿瘤：采用现代外科质量指标的回顾性分析237例报告
Daniel Azoulay,Pio Corleone,Goudarz T Passand et al.
Daniel Azoulay et al.
Objective: Analysis of 6-segmentectomies coded H145678 or H123458 in the New World classification of liver resections using contemporary indicators to improve the shared surgical decision-making. ...
Differential Effects of VEGFA and EGF Polymorphisms on Susceptibility and Postoperative Outcome in Cholangiocarcinoma [0.03%]
VEGFA和EGF基因多态性对胆管癌易感性和术后预后的影响研究
Justus Pein,Saskia Niklisch,Paul Horn et al.
Justus Pein et al.
Objective: To investigate the impact of VEGFA and EGF genetic polymorphisms on postoperative survival, susceptibility, transcriptomics, and systemic proteomic regulation in cholangiocarcinoma (CCA). ...
Neoadjuvant Immunotherapy Using PD-1 Inhibitors for Resectable Stage III Cutaneous Melanoma-Different Outcomes Between Patients With Lymph Node and In-transit Metastases [0.03%]
可切除III期皮肤黑色素瘤新辅助免疫治疗的临床研究——针对区域淋巴结及卫星灶/浸润灶转移患者的不同疗效分析
Ellen Krabbe,Anne Huibers,Ana Carneiro et al.
Ellen Krabbe et al.
Background and aims: Neoadjuvant immunotherapy has emerged as the preferred treatment strategy for patients with resectable stage III melanoma. However, real-world data remain limited, especially regarding patients with i...
Overall Outcomes of Liver Transplantation Using Upfront Normothermic Machine Perfusion: A Real-World Single-Center Experience [0.03%]
肝脏移植术中运用初始常温机械灌注的总体疗效：单一中心的真实世界体验
Michelle C Nguyen,Stephanie Y Ohara,Michele Barnhill et al.
Michelle C Nguyen et al.
Objective: To determine whether normothermic machine perfusion (NMP) mitigates the historical survival disadvantage of donation after circulatory death (DCD) liver transplantation compared with donation after brain death ...
Moving the Needle: Shifting to Earlier Catheter Removal in Diverticular Colovesical Fistula Disease [0.03%]
移针换孔：憩室性膀胱肠瘘病的早期导管移除转换研究
Lindsey M Reynolds,Susanna S Hill
Lindsey M Reynolds
Statewide Analysis Demonstrates Substantial De-implementation of Sentinel Lymph Node Biopsy in Women Over 70, Yet Variation Persists [0.03%]
州范围内的分析表明，70岁以上妇女的哨兵淋巴结活检实施显著减少，但仍存在差异
Christina Fleischer,Alison Baskin,Wenjing Weng et al.
Christina Fleischer et al.
Impact of CYP2A6 Genotype on Survival Outcomes in Patients With Pancreatic Ductal Adenocarcinoma Receiving Perioperative S-1 Therapy [0.03%]
CYP2A6基因型对围手术期S-1治疗胰腺导管腺癌患者生存结局的影响
Yuya Miura,Sumiko Ohnami,Keiichi Ohshima et al.
Yuya Miura et al.
Objective: To evaluate the impact of CYP2A6 genetic polymorphisms on survival outcomes in patients with pancreatic ductal adenocarcinoma (PDAC) receiving perioperative S-1 therapy. ...
Anatomical and Histologic Response to Neoadjuvant Therapy: Recurrence Patterns Among Poor Responders. A Multi-institutional Observational Cohort Study [0.03%]
新辅助治疗的解剖学和组织学反应：多机构观察队列研究中的较差应答者的复发模式
Andrea Baldo,Miho Akabane,Abdulaziz Elemosho et al.
Andrea Baldo et al.
Objective: To characterize the prognostic implications after hepatectomy for colorectal liver metastases (CRLM) by integrating anatomical response to neoadjuvant therapy (NAT), quantified using the Tumor Burden Score rati...